Not long ago, most sleep supplements had a simple goal: help people fall asleep faster.
Today, that's no longer enough.
Consumers increasingly recognize that a good night's sleep isn't just about how quickly they fall asleep—it's about staying asleep, waking up refreshed, and managing the stress that often disrupts healthy sleep in the first place. As a result, brands are beginning to rethink how sleep products should be formulated.
This shift is happening alongside remarkable market growth. The global sleep economy was valued at approximately USD 434 billion in 2024 and is projected to exceed USD 700 billion by 2031. Among all categories, dietary supplements continue to be one of the fastest-growing segments, driven by increasing awareness of sleep health and emotional well-being.
For ingredient suppliers and supplement brands alike, the opportunity is no longer about introducing another sleep ingredient. It's about developing solutions that are supported by science and designed around how sleep actually works.
For years, melatonin has dominated the sleep supplement category, while ingredients such as GABA have become popular for promoting relaxation.
Both remain important, but they don't address every reason why people struggle with sleep.
Many sleep problems today are closely linked to chronic stress. Long working hours, constant digital connectivity, and emotional pressure can keep the body's stress-response system activated long after bedtime. Even when consumers fall asleep, they may still experience frequent waking, light sleep, or poor recovery the following morning.
This is where Ashwagandha has attracted growing scientific and commercial interest.
Unlike ingredients that primarily support sleep onset, Ashwagandha is widely studied as an adaptogen that helps the body adapt to stress by supporting a healthy hypothalamic-pituitary-adrenal (HPA) axis response. Rather than targeting only one stage of sleep, it addresses one of the underlying physiological factors that often contributes to poor sleep quality.
That makes Ashwagandha an increasingly valuable component in next-generation sleep formulations, particularly as consumers begin looking for solutions that support both sleep and emotional wellness.
As the market matures, formulation strategies are changing.
Simply combining more ingredients or increasing dosages is becoming less attractive to both brands and consumers. Instead, the industry is moving toward formulations that target multiple biological pathways while providing stronger scientific evidence for efficacy.
This thinking inspired the development of the NF TriSolve® Sleep Health Solution.
Rather than focusing on a single active ingredient, the solution is built around three interconnected biological pathways involved in healthy sleep.
Melatonin helps regulate the body's biological clock, supporting the transition into sleep.
Ingredients including GABA, L-theanine, and magnesium glycinate help promote relaxation and support sleep maintenance by reducing excessive neural excitation.
Ashwagandha helps support a healthy stress response, addressing one of the most common underlying causes of poor-quality sleep.
Together, these pathways are designed to support falling asleep, staying asleep, and improving overall sleep quality, offering a broader approach than formulations built around a single mechanism alone.
Choosing the right ingredients is only part of the equation.
Many botanical actives face challenges such as poor stability or limited bioavailability, making it difficult to achieve consistent performance in finished products.
To address this challenge, Natural Field integrates its proprietary NF TriSolve® precision co-loaded liposomal delivery technology, co-encapsulating Ashwagandha actives with melatonin within the same liposomal carrier.
This delivery strategy is designed to protect sensitive ingredients during digestion while improving absorption and enabling synergistic activity between the two compounds.
For brands, this creates the possibility of delivering stronger performance without relying solely on higher ingredient dosages—an increasingly important advantage as the industry shifts away from "more is better" formulation strategies.
Innovation in sleep health should be supported by more than formulation concepts alone.
To better understand how different formulations influence sleep, Natural Field established a comprehensive evaluation platform using internationally recognized zebrafish insomnia models. Because zebrafish share highly conserved sleep-related genes with humans, they have become an increasingly valuable model for sleep research.
Rather than measuring only a single endpoint, the research combines multiple layers of evaluation.
Behavioral analysis tracks nighttime activity and wake duration through high-resolution video monitoring, while molecular analysis examines the expression of key sleep-related genes using qRT-PCR.
The research also compares proprietary formulations against multiple reference groups, including commercial melatonin products, botanical sleep supplements, single-ingredient controls, and untreated insomnia models.
This comprehensive evaluation framework provides a clearer understanding of how formulation design translates into biological performance—and helps guide future product development with stronger scientific confidence.
The complete experimental findings and formulation rationale will be shared during our upcoming scientific forum.
Scientific innovation doesn't happen overnight. It advances through continuous research, formulation optimization, and rigorous validation.
To share the latest progress, Natural Field will host the:
2026 Brain Health, Sleep & Mood Innovation Forum
From Botanical Active Innovation to Precision Delivery: Scientific Advances in the NF TriSolve® Sleep Health Solution
August 24, 2026
1:00 PM – 4:00 PM
Xi'an International Convention & Exhibition Center, Xi'an, China
During the forum, our R&D team will present the scientific thinking behind the NF TriSolve® Sleep Health Solution, including:
Why stress adaptation is becoming a critical target in modern sleep formulations.
The rationale behind the three-pathway sleep health framework.
Advances in precision co-loaded liposomal delivery technology.
Scientific validation using internationally recognized zebrafish sleep models.
Future opportunities for next-generation sleep supplement development.
Although the forum will take place in China, the research behind it reflects our broader commitment to supporting the global nutraceutical industry through science-driven innovation. We look forward to sharing new insights with formulation partners, brand owners, and industry professionals from around the world.
The future of sleep supplements will likely be defined not by individual ingredients, but by scientifically designed systems that address sleep from multiple biological perspectives.
Ashwagandha represents an important step in that evolution. Combined with precision delivery technologies and evidence-based formulation strategies, it opens new possibilities for brands seeking differentiated sleep health products.
As research continues to deepen our understanding of sleep biology, the next generation of innovation will belong to solutions that integrate botanical science, advanced delivery technologies, and rigorous scientific validation.
We look forward to sharing more of that journey with our partners on August 24.
Professor and Ph.D. Supervisor, School of Pharmaceutical Sciences, Southern Medical University. Head of the Functional Ingredient R&D Center, Natural Field. Professor Chong Li is a distinguished researcher in the field of advanced drug delivery systems and pharmaceutical technology innovation.
EN
es 
jp 
ko 
fr 
de 
it 
ru 
pt 
th 
ar 
ms 
